Latest stories on OVID
Ovid Therapeutics to Participate in Upcoming Investor Conferences | OVID Stock News
StockTitan53 · neutralgeneral
Ovid Therapeutics Expands Board, Appoints New Scientific Director
TipRanks58 · neutralgeneral
OVID news roundup. 3 stories in the past week, 3 over 30 days. Average 30-day sentiment is 56.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.